Ambea AB (publ) (AMBEA.ST)

SEK 98.05

(1.24%)

EBITDA Summary of Ambea AB (publ)

  • Ambea AB (publ)'s latest annual EBITDA in 2023 was 2.28 Billion SEK , up 0.2% from previous year.
  • Ambea AB (publ)'s latest quarterly EBITDA in 2024 Q1 was 593 Million SEK , up 19.8% from previous quarter.
  • Ambea AB (publ) reported an annual EBITDA of 2.03 Billion SEK in 2022, up 24.02% from previous year.
  • Ambea AB (publ) reported an annual EBITDA of 1.65 Billion SEK in 2021, up 2.47% from previous year.
  • Ambea AB (publ) reported a quarterly EBITDA of 547 Million SEK for 2024 Q2, down -7.76% from previous quarter.
  • Ambea AB (publ) reported a quarterly EBITDA of 495 Million SEK for 2023 Q4, down -28.57% from previous quarter.

Annual EBITDA Chart of Ambea AB (publ) (2023 - 2014)

Historical Annual EBITDA of Ambea AB (publ) (2023 - 2014)

Year EBITDA EBITDA Growth
2023 2.28 Billion SEK 0.2%
2022 2.03 Billion SEK 24.02%
2021 1.65 Billion SEK 2.47%
2020 1.61 Billion SEK 17.7%
2019 1.37 Billion SEK 144.34%
2018 602 Million SEK 18.61%
2017 571 Million SEK 4.05%
2016 374 Million SEK 42.77%
2015 330 Million SEK 86.23%
2014 221 Million SEK 0.0%

Peer EBITDA Comparison of Ambea AB (publ)

Name EBITDA EBITDA Difference
Attendo AB (publ) 3.11 Billion SEK 26.774%
Humana AB (publ) 457 Million SEK -399.125%
ProstaLund AB (publ) -16.57 Million SEK 13864.181%